Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial

Journal:

Clinical Infectious Diseases

Published:

2026-06-04

DOI:

10.1093/cid/ciag335

Affiliations:

21

Authors:

27

Go to article

Institutions	Authors	Share
Duke University Health System, United States of America (USA)	4.000000	0.15
Vanderbilt University Medical Center (VUMC), United States of America (USA)	2.500000	0.09
University of Minnesota (UMN), United States of America (USA)	2.000000	0.07
Stanford University, United States of America (USA)	2.000000	0.07
University of Virginia (UVA), United States of America (USA)	1.000000	0.04
Weill Cornell Medicine, United States of America (USA)	1.000000	0.04
Duke University, United States of America (USA)	1.000000	0.04
Stakeholder Advisory Committee, Pittsburgh, United States of America (USA)	1.000000	0.04
Jadestone Clinical Research, LLC, United States of America (USA)	1.000000	0.04
L and A Morales Healthcare, Inc, United States of America (USA)	1.000000	0.04
Endeavor Health, United States of America (USA)	1.000000	0.04
GCF of Southeastern Michigan, United States of America (USA)	1.000000	0.04
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	1.000000	0.04
University of Mississippi Medical Center (UMMC), Ole Miss, United States of America (USA)	1.000000	0.04
University of Miami (UM), United States of America (USA)	1.000000	0.04
Johns Hopkins University (JHU), United States of America (USA)	1.000000	0.04
Temple University, United States of America (USA)	1.000000	0.04
University of Pittsburgh Medical Center (UPMC), United States of America (USA)	1.000000	0.04
NIH National Center for Advancing Translational Sciences (NCATS), United States of America (USA)	1.000000	0.04
Foundation for the National Institutes of Health (FNIH), United States of America (USA)	1.000000	0.04
VA Tennessee Valley Healthcare System, United States of America (USA)	0.500000	0.02